martes, 21 de noviembre de 2017

Breast Cancer - Nov 20, 2017 Edition

 
 November 20, 2017 
 Breast Cancer 
 The latest breast cancer news from News Medical 
 Mount Sinai researchers identify new therapeutic target for ER+ breast cancerMount Sinai researchers identify new therapeutic target for ER+ breast cancer
 
Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.
 
 
 Research highlights potential solutions to fill policy gaps and advance breast cancer control in AsiaResearch highlights potential solutions to fill policy gaps and advance breast cancer control in Asia
 
Education conducted by civil society can play an important role in filling breast cancer policy gaps and advancing cancer control, including advanced breast cancer, researchers report at the ESMO Asia 2017 Congress.
 
   Indonesian study finds low rates of awareness about cervical and breast cancer screeningIndonesian study finds low rates of awareness about cervical and breast cancer screening
 
Just one in five Indonesian women are aware of cervical cancer screening, according to a study presented at the ESMO Asia 2017 Congress. The research in nearly 5,400 women also found that only 5% knew about mammography for early detection of breast cancer.
 
   Type 2 diabetes linked to increased risk of aggressive breast cancer in African American womenType 2 diabetes linked to increased risk of aggressive breast cancer in African American women
 
African American women with type 2 diabetes (often referred to as adult-onset diabetes) are at a greater risk for developing breast cancer.
 
   Women with ER-positive breast cancer face disease recurrence risk years after treatment endsWomen with ER-positive breast cancer face disease recurrence risk years after treatment ends
 
Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer returning or spreading, according to a new analysis from an international team of investigators published in the New England Journal of Medicine.
 
 Study explores feasibility of mainstreaming genetic counseling for ovarian cancer
 
Study explores feasibility of mainstreaming genetic counseling for ovarian cancerA study that looked at mainstreaming genetic counseling for ovarian cancer to support screening programs in Malaysia was presented at the ESMO Asia 2017 Congress.
 
 
 Study explores reasons for underrepresentation of minorities in genetic cancer research
 
Study explores reasons for underrepresentation of minorities in genetic cancer researchSocio-cultural and clinical factors as well as healthcare processes were important drivers of a woman's willingness to provide saliva specimens for future cancer research.
 
 
 ESMO Consortium Study advocates for equal access to quality cancer treatment across Asia
 
ESMO Consortium Study advocates for equal access to quality cancer treatment across AsiaThe European Society for Medical Oncology opened its 3rd ESMO Asia Congress today, once again in Singapore, attracting close to 3000 regional and international cancer doctors with leading researchers and experts to promote advances in science, diagnosis, treatment, and best practices for cancer patients in Asia.
 
 
 Researchers develop new tool to share clinico-genomic data
 
Researchers develop new tool to share clinico-genomic dataResearchers from Universidad Politécnica de Madrid have developed a new tool that provides standard and shared clinico-genomic data among European healthcare institutions.
 
 
 Epigenetic editing in healthy breast cells can set off chain reaction for tumor initiation
 
Epigenetic editing in healthy breast cells can set off chain reaction for tumor initiationChanging the epigenetic code of a single gene is enough to cause a healthy breast cell to begin a chain reaction and become abnormal, according to research by Queen Mary University of London.
 
 
 Talking-based therapy could transform aftercare for cancer survivors
 
Talking-based therapy could transform aftercare for cancer survivorsA new project to develop and test a talking-based therapy for cancer survivors, led by Queen Mary University of London, Barts Health NHS Trust and King's College London, has been awarded £2.5m by the National Institute for Health Research.
 
 
 Study highlights need for early identification, treatment of PTSD in cancer survivors
 
Study highlights need for early identification, treatment of PTSD in cancer survivorsA recent study showed approximately one-fifth of patients with cancer experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued to live with PTSD years later.
 
 
 Over-the-counter decongestant found to be effective inhibitor of tumor stroma
 
Over-the-counter decongestant found to be effective inhibitor of tumor stromaCANCER researchers seeking non-toxic alternatives to harmful chemotherapy are reporting a highly significant result for a humble cold remedy.
 

No hay comentarios:

Publicar un comentario